The new diagnostic criteria of ALS (Awaji criteria)

Brain and Nerve

Volumn 59, Issue 10, 2007, Pages 1023-1029

  Nodera, Hiroyuki ^a   Izumi, Yuishin ^a   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Diagnostic criteria; Electrodiagnosis; IFCN

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DIAGNOSTIC PROCEDURE; ELECTRODIAGNOSIS; HUMAN;

AMYOTROPHIC LATERAL SCLEROSIS; EARLY DIAGNOSIS; ELECTRODIAGNOSIS; HUMANS; REFERENCE STANDARDS;

EID: 35348961069     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Eisen A: Clinical electrophysiology of the upper and lower motor neuron in amyotrophic lateral sclerosis. Semin Neurol 21: 141-154, 2001
2. Dengler R, von Neuhoff N, Bufler J, Krampfl K, Peschel T, et al: Amyotrophic lateral sclerosis: new developments in diagnostic markers. Neurodegener Dis 2: 177-184, 2005
3. Habert MO, Lacomblez L, Maksud P, El Fakhri G, Pradot JF, et al: Brain perfusion imaging in amyotrophic lateral sclerosis: extent of cortical changes according to the severity and topography of motor impairment. Amyotroph Lateral Scler 8: 9-15, 2007
4. Han J, Ma L: Functional magnetic resonance imaging study of the brain in patients with amyotrophic lateral sclerosis. Chin Med Sci J 21: 228-233, 2006
5. Wang S, Poptani H, Bilello M, Wu X, Woo JH, et al: Diffusion tensor imaging in amyotrophic lateral sclerosis: volumetric analysis of the corticospinal tract. AJNR Am J Neuroradiol 27: 1234-1238, 2006
6. Bowser R, Cudkowicz M, Kaddurah-Daouk R: Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn 6: 387398, 2006
7. Brettschneider J, Petzold A, Sussmuth SD, Ludolph AC, Tumani H, Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 66: 852-856, 2006
8. Kolarcik C, Bowser R: Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease. Mol Diagn Ther 10: 281-292, 2006
9. Lambert EH: Electromyography in amyotrophic lateral sclerosis, (eds by) Norris FH, Kurland LT, In: Motor Neuron Diseases: Research on Amyotrophic Lateral Sclerosis and Related Disorders. Grune & Stratton, New York, pp135-153, 1969
10. Comblath DR, Kuncl RW, Mellits ED, Quaskey SA, Clawson L, et al: Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 15: 1111-1115, 1992
11. Arunachalam R, Osei-Lah A, Mills KR: Transcutaneous cervical root stimulation in the diagnosis of multifocal motor neuropathy with conduction block. J Neurol Neurosurg Psychiatry 74: 1329-1331, 2003
12. Nodera H, Bostock H, Izumi Y, Nakamura K, Urushihara R, et al: Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test. Neurology 67: 280-287, 2006
13. Brooks BR: El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/ Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 124 (Suppl): 96-107, 1994
14. Beghi E, Balzarini C, Bogliun G, Logroscino G, Manfredi L, et al: Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis. Neuroepidemiology 21: 265-270, 2002
15. Belsh JM: ALS diagnostic criteria of El Escorial Revisited: do they meet the needs of clinicians as well as researchers ? Amyotroph Lateral Scler Other Motor Neuron Disord 1 (Suppl 1): S57-60, 2000
16. Meininger V: Getting the diagnosis right: beyond El Escorial. J Neurol 246 (Suppl 3): 11110-12, 1999
17. Wilbourn AJ: Clinical neurophysiology in the diagnosis of amyotrophic lateral sclerosis: the Lambert and the El Escorial criteria. J Neurol Sci 160 (Suppl 1): S25-29, 1998
18. van Schaik IN, Bouche P, Illa I, Leger JM, Vanden Bergh P, et al: European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol 13: 802-808, 2006
19. Echaniz-Laguna A, Degos B, Mohr M, Kessler R, Urban-Kraemer E, et al: A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP. Muscle Nerve 33: 356-362, 2006
20. Rajabally YA, Jacob S, Hbahbih M: Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases. J Peripher Nerv Syst 10: 282-292, 2005
21. Said G: Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 16: 293-303, 2006
22. Brooks BR: Diagnostic dilemmas in amyotrophic lateral sclerosis. J Neurol Sci 165 (Suppl 1): S1-9, 1999
23. Traynor BJ, Codd MB, Corr B, Forde E, Hardiman OM, Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 57: 1171-1176, 2000
24. Hawkins RC: The evidence based medicine approach to diagnostic testing: practicalities and limitations. Clin Biochem Rev 26: 7-18, 2005
25. Jaeschke R, Guyatt G, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 271: 389-391, 1994
26. Jaeschke R, Guyatt GH, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271: 703-707, 1994
27. Borasio GD, Robberecht W, Leigh PN, Emile J, Guiloff RJ, et al: A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology 51: 583-586, 1998
28. Cudkowicz ME, Shefner JM, Schoenfeld DA, Broun RH Jr, Johnson H, et al: A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 61: 456-464, 2003
29. Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KJ, et al: Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol 60: 22-31, 2006
30. Graf M, Ecker D, Horowski R, Kramer B, Riederer P, et al: High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm 112: 649-660, 2005
31. Miller RG, Moore DH 2nd, Gelinas DF, Dronsky V, Mendoza M, et al: Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 56: 843-848, 2001
32. Miller RG, Smith SA, Murphy JR, Brinkmawn JR, Graves J, et al: A clinical trial of verapamil in amyotrophic lateral sclerosis. Muscle Nerve 19: 511-515, 1996
33. Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, et al: A clinical trial of creatine in ALS. Neurology 63: 1656-1661, 2004
34. Bos MM, Overeem S, van Engelen BG, Scheffer H, Vanden Elzen C, et al: A case of neuromuscular mimicry. Neuromuscul Disord 16: 510-513, 2006
35. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, et al: Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 57: 109-113, 2000
36. Wokke JH: Confounding effects of mimicking disorders in the early diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (Suppl 1): S61-63, 2000
37. Nobile-Orazio E, Cappellari A, Priori A: Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 31: 663-680, 2005
38. Thaisetthawatkul P, Logigian EL, Herrmann DN: Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 59: 1526-1532, 2002
39. Hirota N, Eisen A, Weber M: Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy's disease. Muscle Nerve 23: 1872-1875, 2000
40. Komissarow L, Rollnik JD, Bogdanova D, Krampfl K, Khabivov FA, et al: Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol 115: 356-360, 2004
41. Magistris MR, Rosler KM, Truffert A, Landis T, Hess CW: A clinical study of motor evoked potentials using a triple stimulation technique. Brain 122 (Pt 2): 265-279, 1999
42. Rosler KM, Magistris MR: Triple stimulation technique (TST) in amyotrophic lateral sclerosis. Clin Neurophysiol 115: 1715, 2004